The Epigenomics of Migraine.

Research on migraine has recently focused on epigenetic mechanisms, which influence gene expression. These mechanisms include DNA methylation, non-coding RNAs, and histone modifications. Changes in DNA methylation have been found in genes like CALCA and RAMP1. These genes play important roles in the CGRP signaling pathway, which is linked to migraines. Additionally, non-coding RNA studies have helped create risk scores to identify different migraine types. This can improve clinical diagnosis for patients. Valproic acid, a common migraine treatment, may work by modifying histones and affecting gene expression. Understanding these epigenetic changes can enhance our approach to migraine treatment. By combining this knowledge with genetic information, we can develop more personalized medical strategies. This research highlights the complex interaction between genetic factors and environmental influences in migraine development and management, paving the way for better therapies in the future. Clinical relevance: This research indicates that understanding epigenetic mechanisms may lead to improved migraine treatments tailored to individual patients' genetic and environmental profiles.